See also COX-2 inhibitors (coxibs)

General information

The clinical development flosulide, a COX-2 inhibitor, was discontinued because of nephrotoxicity [ ]. Measurement of renal prostaglandin synthesis did not predict its nephrotoxicity in single-dose and short-term studies [ ].

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here